Factors Associated With Initiation and Completion of Human Papillomavirus Vaccine Series Among Young Women Enrolled in Medicaid

Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine

“…The main barriers for the implementation of HPV vaccination were then thought to be the cost, insufficient knowledge of the women about cervical cancer and the benefits of immunization, and, in a lesser degree, concerns about the efficacy and safety of the vaccine [24][25][26][27][28][29]. However, more recent studies have reported low rates of vaccination, despite the implementation of HPV immunization programs from health care systems around the world [24,25,30].…”

Compliance with Age at Initiation of Human Papillomavirus Vaccine Series by Socioeconomic Status, Race/Ethnicity, and Health Insurance Coverage Among 13-17 Year-Old Females Who Received at Least One HPV Vaccine Shot: United States, 2011

“…This decrease is thought to be due to the success of public health preventions and wide-scale implementation of Pap smear screenings (15). Despite this reduction, non-Hispanic Blacks and Hispanics are less likely than non-Hispanic Whites to initiate the HPV vaccination series (18,19,20,21).…”

Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia without colposcopic tissue information; a step toward automation for low resource settings

“…Other important obstacles include: 1) dissemination of the vaccine, which has been slow in the United States; 21 2) lack of sufficient understanding of HPV types outside of the developed world; 3) lack of trained personnel in cytology, histopathology, and surgical oncology; and 4) absence of functional cancer registries and plans for follow-up of patients. Figure 1 shows the screening and diagnostic paradigms for both the high-and low-resource settings that are clinically necessary to have an impact on cervical cancer.…”